Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts

Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts

Abstract Introduction Adverse metabolic effects related to dolutegravir (DTG) are increasingly reported as countries are adopting DTG‐based regimens as first‐line antiretroviral therapy (ART), but there is limited data from sub‐Saharan Africa. We explored changes in body weight pre‐ and post‐switch...

Full description

Saved in:
Bibliographic Details
Main Authors: Thierry Tiendrebeogo, Karen Malateste, Armel Poda, Albert Minga, Cecile D. Lahiri, Oliver Ezechi, Didier K. Ekouevi, Igho Ofotokun, Antoine Jaquet, the IeDEA West Africa Collaboration
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of the International AIDS Society
Subjects:
HIV
antiretroviral therapy
dolutegravir
weight gain
observational cohort study
West Africa
Online Access:https://doi.org/10.1002/jia2.26371
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jia2.26371

Similar Items